Doctor-led weight-loss care at our TRT Bangkok clinic in Pattaya, with cold-chain delivery across Thailand.
Treatments supervised by Dr. Kenika Norrachetdecha
Medical Director · Thai License #72509
Personal consultation included with every program
Two ways to start · transparent pricing
Two ways to start — take-home pens or a walk-in in-clinic shot. Prices are indicative; your exact figure is confirmed in a private medical review at TRT Bangkok Clinic in Pattaya.
The full-strength dose most patients build up to — for maximum, lasting results (up to 20.9% body-weight loss in trials).
Ask about the 15 mg program →The easiest way to start — nothing to handle yourself, no cold-chain to manage at home.
Doctor-administered · Pattaya clinic · View on Google Maps →
Ask about in-clinic shots →Full dose ladder · every strength
Not sure which dose? Your doctor sets your starting pen and titration. Ask the clinic on WhatsApp →
That's −17.8 kg — you'd weigh .
Based on the 20.9% trial-mean. Individual outcomes vary.Operational excellence you can see, not just words. Below is one unbroken cold chain in two halves — how we receive & verify your authentic Mounjaro, and how we keep it cold all the way to your door. A dedicated pharma department, small fast-rotating fresh stock and a GDP medical courier mean every dose stays authentic, fresh and fully effective.
With Mounjaro you know exactly what you receive. Every pen reaches us through Zuellig Pharma — Eli Lilly's appointed pharmaceutical distributor in Thailand — inside a temperature-monitored cold chain, and you can verify the Eli Lilly manufacturer markings yourself before your first injection.
Every pen carries the Eli Lilly logo, the brand name "Mounjaro", lot number, NDC code, and expiration date — identical to pens dispensed in US and EU pharmacies. We do not unbox or relabel.
Every shipment travels refrigerated through Zuellig Pharma — Eli Lilly's appointed Thai distributor — and is held in our monitored clinic fridge inside the 2–8°C (36–46°F) range, from warehouse to your hands.
Your first dose is administered by Dr. Kenika or our nurse — in clinic in Pattaya, at your hotel in Bangkok, or via guided video for remote patients. You can inspect the pen markings before injection.
Every patient receives the lot number and expiration date of their pen on the prescription record. You can cross-check against Eli Lilly's batch documentation on request.
When you order, your Mounjaro comes straight from our refrigerated clinic stock — kept small and fast-rotating (about two weeks’ supply, reordered before it runs low) so every pen is fresh, never warehouse-aged. We pack it cold and a GDP medical courier delivers it to your door under an unbroken 2–8°C chain.
Your Mounjaro leaves our clinic fridge into an insulated box with a 2–8°C “Temperature Sensitive” label.
Boxes wait in the Inter Express Logistics cold room — temperature-monitored — until they ship.
Handed to Inter Express Logistics — a GDP-standard courier moving vaccines and medicines to hospitals nationwide for 20+ years.
Mounjaro did not arrive in a vacuum. It is the latest product of a research program that has shaped diabetes medicine since 1876 — when Eli Lilly founded the company in Indianapolis, decades before insulin itself existed as a treatment.
In Thailand, both the type-2 indication (Mounjaro) and the engineered manufacturing chain behind it are imported under the same Thai-FDA registration. There is no "generic tirzepatide" — only the Lilly-manufactured product.
This is how Mounjaro works for weight loss — it activates two gut-hormone receptors at once. Single-receptor GLP-1 agonists like semaglutide bind only the GLP-1 receptor. Tirzepatide co-activates the glucose-dependent insulinotropic polypeptide (GIP) receptor at the same time. That second axis is what separates the SURPASS efficacy curves from everything that came before.
GLP-1 receptor activation slows gastric emptying, amplifies postprandial insulin release, and signals satiety centrally through hypothalamic POMC neurons. This is the axis every GLP-1 drug shares — Wegovy, Ozempic, Saxenda, Trulicity, Victoza.
GIP-receptor agonism improves insulin sensitivity inside adipose tissue, suppresses lipolysis appropriately in the fed state, and appears to attenuate the nausea ceiling that limits GLP-1 dose escalation — patients tolerate higher exposure.
Head-to-head evidence — SURPASS-2. Frias and colleagues randomised 1,879 adults with type-2 diabetes to tirzepatide 5/10/15 mg or semaglutide 1 mg, all once-weekly, over 40 weeks. Mean body-weight change at week 40 was −7.6, −9.3 and −11.2 kg for the three tirzepatide doses respectively, versus −5.9 kg for semaglutide 1 mg (NEJM 2021).
Receptor-level proof. Coskun and colleagues characterised the LY3298176 binding profile against both GIP and GLP-1 receptors, showing −5× higher affinity for GIP and modestly lower than native GLP-1 for the GLP-1 receptor — the deliberate "imbalanced" signature that gives tirzepatide its distinct metabolic signal (Mol Metab 2018).
Tirzepatide is escalated in 2.5 mg increments every four weeks. Each rung gives the gastrointestinal tract a full month to adapt before the next jump. Most patients reach a steady-state therapeutic dose between 10 mg and 15 mg.
A patient can stay at any step indefinitely once weight goals are met. There is no clinical requirement to climb to 15 mg if the target was hit at 7.5 or 10 mg.
Tirzepatide is the strongest weight-loss molecule on the market, but it is not the right first choice for every patient. The categories below help you and the prescribing doctor decide whether Mounjaro or one of the other three GLP-1 agents is the better starting point.
Prescribed and supervised by our own doctor.
Licensed medical facility · Real photos · Dr. Kenika
Trajectory based on the SURMOUNT-1 clinical-trial mean. Your individualized program is confirmed in consultation — this is an evidence-based estimate, not a guarantee.
Your trajectory · based on SURMOUNT-1 mean (Mounjaro)
Estimator uses peer-reviewed clinical-trial mean data. Individual outcomes vary based on adherence, baseline BMI, comorbidities, and lifestyle factors. Final program plan determined in private medical consultation.[ref]
Doctor-led · Authentic Eli Lilly · Cold-Chain
↑ Take-home pens available from 13,990 ฿
Mounjaro (tirzepatide) delivers 20.9% body-weight reduction in clinical trials — the strongest evidence-based outcome in the GLP-1 class. Dual GIP & GLP-1 receptor action; FDA-approved (T2D label, weight-loss off-label) and pharmacologically identical to FDA-weight-management-approved Zepbound.
Per-shot pricing at higher doses confirmed during your consultation. Final program pricing depends on your dose plan and treatment duration. Thai pharmacy advertising regulations preclude binding online prices — your exact figure is shared in private medical review.
15-minute WhatsApp with our clinic team. Share your goals, history, and questions. No commitment.
Dr. Kenika reviews your history. Labs ordered if needed. Treatment plan decided based on your specific clinical picture.
First dose at clinic or cold-chain delivery to your address. Titration plan + side-effect support from day one.
Weekly check-ins during titration. Dose adjusted to your response. Sustainable maintenance plan together.
Three access paths — choose what fits your location and schedule. All paths supervised by Dr. Kenika.
Walk into our Nongprue clinic for a personal consultation with Dr. Kenika. Authentic Mounjaro dispensed on site. First-visit administration where clinically appropriate.
Visit Pattaya Clinic →Premium concierge service: our nurse comes to your Bangkok hotel, condo, or office with the medicine ready. Video consultation with Dr. Kenika first.
Book Bangkok Concierge →Video consultation with Dr. Kenika. Cold-chain delivery of authentic Mounjaro to your Phuket address. Self-injection with WhatsApp support.
Start Remote Program →Real Eli Lilly Mounjaro, delivered to us through Zuellig Pharma’s cold chain — batch number and expiry intact, and you verify the manufacturer markings yourself before your first dose. No compounded substitutes, no grey-market sourcing.
We hold only a small, fast-rotating stock at 2–8°C and ship it under an unbroken cold chain — so every pen is fresh, never heat-damaged, and works exactly as intended.
Every plan is personally supervised by Dr. Kenika, and a dedicated pharma department handles sourcing, storage and cold-chain transport — so we’re reliably in stock, never sold out.
Real reviews from real patients on Google Business Profile. Currently 5.0 ★ verified reviews — and growing. Reviews are updated regularly.
Request a consultation. Our clinic team responds within minutes on WhatsApp and walks you through eligibility, dose plan, sourcing verification, and the access mode that fits your location.
Get started on WhatsApp
FDA prescribing information, peer-reviewed clinical trials, and manufacturer documentation.
Additional clinical questions are discussed during your private consultation with Dr. Kenika.
Each GLP-1 protocol has a different mechanism, trial profile, and outcome ceiling. Compare or explore by location.
Same active molecule as Mounjaro. Lower-cost option through licensed Thai pharmaceutical channels.
See program →
Most-prescribed GLP-1 in clinical practice. Excellent track record for goals up to 15%.
See program →
Investigational GLP-1/GIP/Glucagon triple agonist. Highest documented mean reduction in incretin trials.
See program →
In-person consultation, baseline labs, same-week start. Walk-in friendly.
See program →